Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Titan Pharmaceuticals Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 24 | 24 | 0 |
| Shares | 1.30M | 665.4K | −633.0K (−48.8%) |
| Value | $1.24M | $371.0K | −$869.0K (−70.1%) |
New holders (4)
Institutions that held Titan Pharmaceuticals Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 62,333 | $35.0K | 0.00% |
| HRT Financial LP | 52,108 | $29.0K | 0.00% |
| Ergoteles LLC | 18,978 | $11.0K | 0.00% |
| Citigroup Inc | 1,755 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Titan Pharmaceuticals Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Armistice Capital, LLC | 863,512 | $826.0K |
| Barclays PLC | 50,050 | $48.0K |
| Tower Research Capital LLC (TRC) | 10,041 | $10.0K |
| Fortitude Advisory Group L.L.C. | 8 | $0 |